(Q40377124)

20 September 2017

title

Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses (English)

1 reference

20 September 2017

George M Bahr

1

1 reference

20 September 2017

publication date

1 November 2005

1 reference

Expert Review of Clinical Immunology

20 September 2017

published in

1 reference

20 September 2017

volume

1

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

529-547

1 reference

B lymphocyte dysfunctions in HIV infection

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

B-cell activation and lymphoma in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Loss of memory (CD27) B lymphocytes in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Cellular immune responses to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Preferential apoptosis of HIV-1-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The cytokine network in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD4+ Tregs and immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Tregs and allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Regulatory cells and infectious agents: detentes cordiale and contraire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Depletion of regulatory T cells in HIV infection is associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Innate immunity and pathogen-host interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Role of cytokines and chemokines in the regulation of innate immunity and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The search for the CD8+ cell anti-HIV factor (CAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Newly identified host factors modulate HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Molecular characterization of a putative antiretroviral transcriptional factor, OTK18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The supportive role of complement in HIV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Role of complement in the control of HIV dynamics and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV and human complement: inefficient virolysis and effective adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Mannose binding lectin (MBL) and HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

NKT cell subsets in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

NKT cells and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Reciprocal alterations of Th1/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

NK cell compartments and their activation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human natural killer cell function and their interactions with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Mutual interference of HIV and natural killer cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Macrophages and HIV-1: dangerous liaisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human immunodeficiency virus gp120 downregulates CD1d cell surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Toll-like receptors and other links between innate and acquired alloimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Innate immunity and toll-like receptors: clinical implications of basic science research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Toll-dependent control mechanisms of CD4 T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

TLR2 is expressed on activated T cells as a costimulatory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Toll-like receptors and innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Innate sensing of viruses by toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The role of Toll-like receptors in the host response to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The role of dendritic cells in the pathogenesis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

21 January 2018

Innate immunity and HIV.

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The role of dendritic cell C-type lectin receptors in HIV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Antigen presentation and the role of dendritic cells in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Recent advances in the treatment of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Effect of recent thymic emigrants on progression of HIV-1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Immune Reconstitution Strategies in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Highly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Cytokine therapies in HIV-1 infection: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Placebo-controlled trial of prednisone in advanced HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Prospects for immune reconstitution in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Interrupting highly active antiretroviral therapy in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Progress on new vaccine strategies against chronic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Therapeutic vaccination against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

HIV-specific immunity during structured antiviral drug treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Interferon-gamma therapy activates human monocytes for enhanced phagocytosis of Mycobacterium avium complex in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Lessons from history: dysfunctional APCs, inherent dangers of STI and an important goal, as yet unmet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Complement dependent trapping of infectious HIV in human lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.1.4.529

Induction of apoptosis by HIV-1-infected monocytic cells

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.4049/JIMMUNOL.170.3.1566

Identifiers

DOI

10.1586/1744666X.1.4.529

1 reference

20 September 2017

1 reference